प्रतिक्रिया प्राप्त करें | इक्विटी | बाजार | मेट्रोपॉलिटन स्टॉक एक्सचेंज ऑफ इंडिया लिमिटेड (एमएसई)

SHREE GANESH BIO TECH I L (EQ)

  • As on 03 Sep, 2025 09:08:02 IST
  • All prices in
  • refresh
  • प्रतीक:
  • SHREEGANES
  • अंकित मूल्य:
  • 1.00
  • आईएसआईएन:
  • INE051N01026
  • उद्योग:
  • BIOTECHNOLOGY
  • -

    |

  • Pr. Close : 0.75
  • Open : 0.75
  • High : -
  • Low : -
  • Close : 0.75

साप्ताहिक

महीने के

52 सप्ताह

H

-

H

-

H

-

L

-

L

-

L

-
बाजार गहराई

मात्रा खरीदें

कीमत खरीदें

विक्रय मूल्य

मात्रा बेचें

- - - -
- - - -
- - - -
- - - -
- - - -
- कुल मात्रा -
स्टॉक मूल्य आंदोलन
औसत ट्रेडेड मूल्य -
कुल व्यापार मूल्य (Rs. लाखों में) -
कुल ट्रेडेड मात्रा -
2 सप्ताह औसत मात्रा -
Free Float (Cr.) 2.75
Value at Risk (VaR in %)
Security VaR 7.50
Index VaR 10.00
VaR Margin 75.00
Extreme Loss Rate 5.00
Adhoc Margin 0.00
Applicable Margin Rate 80.00
No Details available.
Security-wise Delivery Position
No Details available.

Period

Clarifications

Standalone (01-Jul-2018-30-Sep-2018) -
Standalone (01-Apr-2018-30-Jun-2018) -
Standalone (01-Apr-2017-31-Mar-2018) -
Standalone (01-Jan-2018-31-Mar-2018) -
Standalone (01-Oct-2017-31-Dec-2017) -

Date

Type

Clarifications

No Shareholding Pattern Available

Ex-Date

Purpose

Book Closure / Record Date

19-Sep-2024 AGM 21-Sep-2024 - 28-Sep-2024
18-Sep-2023 AGM 21-Sep-2023 - 28-Sep-2023
19-Sep-2022 Annual General Meeting 21-Sep-2022 - 27-Sep-2022
27-Apr-2022 Bonus 1:1 28-Apr-2022
10-Feb-2022 Sub-division From Rs. 10/- to Re. 1/- 11-Feb-2022
Unaudited Financial Results / Others 07-Feb-2023
Shree Ganesh Bio-Tech (India) Limited(SHREEGANES)
Date : 14-02-2023 12:50:46
Purpose : Unaudited Financial Results / Others
Description :

Shree Ganesh Bio-Tech (India) Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2023 inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2022.

Unaudited Financial Results 03-Nov-2022
Shree Ganesh Bio-Tech (India) Limited(SHREEGANES)
Date : 09-11-2022 09:52:16
Purpose : Unaudited Financial Results
Description :

Shree Ganesh Bio-Tech ( India) Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on November09, 2022, inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and financial year ended September 30, 2022.

Unaudited Financial Results / Others 07-Jul-2022
Shree Ganesh Bio-Tech (India) Limited(SHREEGANES)
Date : 25-07-2022 16:54:15
Purpose : Unaudited Financial Results / Others
Description :

Shree Ganesh Bio-Tech (India) Limited has informed the Exchange that a meeting of the Board of Directors of the Company is scheduled to be held on July 25, 2022, inter-alia to transact the following business:
1. To consider and approve Financial Results of the Company for the quarter ended June 30, 2022.
2. Any other matter with the permission of the Chair.

Audited Financial Results / Others 06-May-2022
Shree Ganesh Bio-Tech (India) Limited(SHREEGANES)
Date : 23-05-2022 10:33:54
Purpose : Audited Financial Results / Others
Description :

Shree Ganesh Bio - Tech (India) Limited has informed the Exchange that the meeting of the Board of Directors is scheduled to be held on May 23, 2022, to consider the following:
1. To consider and approve Financial Results of the Company for the quarter and year ended March 31, 2022 along with Auditor's Report thereon.
2. To consider any other businesses as maybe decided by the Board.

Intimation Of Board Meeting - Bonus 03-Feb-2022
Shree Ganesh Bio-Tech (India) Limited(SHREEGANES)
Date : 07-03-2022 15:15:09
Purpose : Intimation Of Board Meeting - Bonus
Description :

Shree Ganesh Bio-Tech (India) LLimited has informed the Exchange that a meeting of the Board of Directors of the Company will be held at registered office of the company on March 07, 2022 to consider the declaration of issue of bonus shares to the equity shareholders of the company.